Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 183,898 | 156,139 | 116,529 | 80,010 | 317,823 |
| Depreciation Amortization | 105,049 | 82,149 | 54,458 | 27,732 | 114,130 |
| Income taxes - deferred | -29,465 | -29,143 | -19,363 | -9,004 | -37,048 |
| Accounts receivable | -14,314 | -5,395 | 3,498 | -9,965 | -49,034 |
| Other Working Capital | -56,254 | -29,619 | -120,213 | -100,935 | -24,638 |
| Other Operating Activity | 129,662 | 93,136 | 59,750 | 43,822 | 126,520 |
| Operating Cash Flow | $318,576 | $267,267 | $94,659 | $31,660 | $447,753 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -301,854 | N/A | 826 | 10,913 | N/A |
| PPE Investments | -47,928 | -37,218 | -26,053 | -14,452 | -38,089 |
| Net Acquisitions | -38,171 | -38,171 | -38,228 | N/A | -4,500 |
| Purchase Of Investment | -5,000 | -253,156 | -206,231 | -113,147 | -67,101 |
| Sale Of Investment | 108,546 | 84,860 | 34,162 | 2,001 | 64,785 |
| Purchase Sale Intangibles | -11,528 | -11,528 | -11,528 | -11,426 | N/A |
| Other Investing Activity | -11,528 | -11,528 | -11,528 | -11,426 | 0 |
| Investing Cash Flow | $-295,935 | $-255,213 | $-247,052 | $-126,111 | $-44,905 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 57,848 | 53,600 | 35,062 | 21,372 | 122,088 |
| Common Stock Repurchased | -530,486 | -310,486 | -120,486 | -35,573 | -245,864 |
| Dividend Paid | -100,067 | -75,816 | -50,681 | -25,283 | -89,172 |
| Other Financing Activity | -37,853 | -35,429 | -34,155 | -33,355 | -39,567 |
| Financing Cash Flow | $-610,558 | $-368,131 | $-170,260 | $-72,839 | $-252,515 |
| Exchange Rate Effect | -16,744 | -9,698 | -1,541 | -1,310 | 2,720 |
| Beginning Cash Position | 1,233,032 | 1,233,032 | 1,233,032 | 1,233,032 | 1,079,979 |
| End Cash Position | 628,371 | 867,257 | 908,838 | 1,064,432 | 1,233,032 |
| Net Cash Flow | $-604,661 | $-365,775 | $-324,194 | $-168,600 | $153,053 |
| Free Cash Flow | |||||
| Operating Cash Flow | 318,576 | 267,267 | 94,659 | 31,660 | 447,753 |
| Capital Expenditure | -47,928 | -37,218 | -26,053 | -14,452 | -54,454 |
| Free Cash Flow | 270,648 | 230,049 | 68,606 | 17,208 | 393,299 |